Cindy Powers Magrini, PharmD, BCPS

Slides:



Advertisements
Similar presentations
12-1 Chapter 12 Advanced EHR Functionality © 2012 The McGraw-Hill Companies, Inc. All rights reserved. McGraw-Hill.
Advertisements

Daliah Heller, PhD, MPH Assistant Commissioner
Sharon Stancliff, MD Caroline Rath, PA-C Harm Reduction Coalition New York, NY USA.
The Washington State Pharmacist Perspective
Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
Treatment Alternatives to Prison A Health Impact Assessment Scope of research February 2012 Health Impact Assessment – a structured yet flexible research.
13 Principles of Effective Addictions Treatment
Dosing and patient management requirements during induction, stabilization, and detoxification with buprenorphine Matthew A. Torrington MD Clinical Research.
Recognizing and Preventing Overdose and Administering Naloxone Substance Use Disorder Treatment Professional Curricula Core.
PERMEATING BORDERS OVERDOSE PREVENTION Summer Conference 2014 July 24, 2014 ACOPC Allegheny County Overdose Prevention Coalition Presents.
Expanding prescription naloxone Alex Walley & Maya Doe-Simkins on behalf of prescribetoprevent.org prescribetoprevent.org: Jenny Arnold, PharmD, BCPS Leo.
Swinomish Wellness Program
Project Coordinator Overdose Prevention Project, Prevention Point Pittsburgh Alice Bell, LCSW.
New Employee Orientation (Insert name) County Health Department.
.  Introduction to Methadone Maintenance Therapy (MMT)  Introduction to Harm Reduction  Benefits of MMT  One Patient’s Perspective  Misconceptions.
Meeting the health needs of older drug users Dr Muriel Simmonte NHS Lothian Primary Care Facilitator Team/East Lothian Locality Drug Clinic.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
Prescription Drug Monitoring Programs: Analysis of State Level Usage Requirements Matthew Penn, JD, Carla Chen, JD Director, Public Health Law Program.
‘The courts and prisons’. The Courts: 1.Court Integrated Services Programs (C.I.S.P) 2.Court Referral & Evaluation for Drug Intervention & Treatment Program.
Combating the Opioid Abuse Epidemic with Evzio ® (naloxone) Baely Crockett, PharmD Eskenazi Health Internal Medicine PGY2 This speaker has no actual or.
OPIOID SUBSTITUTION THERAPY
In Which Areas Have Clinical Pharmacists Been the Most Successful in Patient Care ? Hospital inpatient unit (wards) –Therapeutic drug monitoring –Anticoagulation.
OVERDOSE SOLUTIONS 2013 PROJECT LIFE LINE AN ACOPC INITIATIVE Sherry Rickard-Aasen.
Rx for Success Next Steps to Prevent Prescription Drug Abuse Rebecca Hebner, MPH Substance Abuse Prevention Systems Coordinator.
For Pain or Not for Pain: Methadone Madness
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
Quaboag Hills Community Coalition Substance Use Task Force October 20, 2014 Overview of the Strategic Prevention Framework (SPF) “Road Map” What are Evidence-Based.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Buprenorphine Treatment for Opioid Dependence CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for.
Trends in Opioid Use and Overdose in BC: Making the case for greater availability of Take Home Naloxone programs Ashraf Amlani Harm Reduction Epidemiologist.
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
The Heroin Epidemic in rural Maryland Rural Health Learning Collaboration Sept. 28, 2015 James A. Cockey, MD, FACP Deputy Health Officer.
Daniel Wermeling, Pharm.D. Professor, College of Pharmacy University of Kentucky.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
ASTHO Prescription Drug Misuse and Abuse Strategic Map:
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
Nebraska’s Prescription Drug Monitoring Program What Do I Really Need to Know? Amy Reynoldson, DHHS Kevin C. Borcher, PharmD,NeHII, Inc.
Oregon Prescription Drug Monitoring Program
Incidental Medical Services (IMS) Department of
Medication Assisted Treatment
or you can use Text Voting by texting ”nmpha” to 22333
Current Concepts in Pain Management
State Targeted Response to Opioid Crisis
OPIOID EPIDEMIC.
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
Opioid Addiction in Tennessee
Nebraska Prescription Drug Overdose Prevention Program Efforts
Caldwell County Narcotic Initiative
COLLECTIVE IMPACT APPROACH TO ADDRESSING
An overdose Reduction PlaN
Opioids – A Pharmaceutical Perspective on Prescription Drugs
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Opioid Crisis A Call to ACTION
Health Home Program Services for Patient 1st Medicaid Recipients
Health Home Program Services
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
MDHHS Response to the Opioid Crisis
Opiate Roundtable March 29, 2018 Karen Burgess, MD
Opioids in Butte County
Prescription Drug Monitoring Program
Pain Management and Substance Use Disorders: JCPP Strategic Session
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Prescription Drug Monitoring Program
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic
Community-Based Strategies for Preventing Opioid Abuse
Strategic Initiatives to Address Opioid Overdose & Addiction
Chapter 8 Healthcare Delivery Systems
PMP Advisory Committee
Presentation transcript:

Cindy Powers Magrini, PharmD, BCPS Clinical Pharmacy Specialist Positive Health Clinic

Naloxone Prescribing at The Positive Health Clinic Cindy Powers Magrini, PharmD, BCPS Clinical Pharmacy Specialist, Positive Health Clinic (PHC) July 31, 2012 2

Introduction to the PHC Clinic offers early HIV intervention and treatment using a harm reduction model Funded through a federal grant under the Ryan White CARE Act of 1990 ~750 HIV-positive patients 5 physicians 2 nurse practitioners 3 nurses 4 social workers 2 medical assistants 1 patient advocate 1 data analyst 1 grant coordinator 1 administrative director 1 pharmacist 3

Cristina Elgins’s Presentation for PHC Staff Local trends in overdose National trends in overdose Strategies for preventing opioid fatalities Prevention Point Pittsburgh Other naloxone prescribers in Pittsburgh Project Lazarus Legality of prescribing naloxone—Temple University School of Law Memo How to treat an overdose situation

Naloxone Prescribed When: 1. Patient release after emergency medical care involving opioid OD/intoxication 2. Suspected history of illicit or nonmedical opioid use 3. High-dose opioid prescription (> 50 mg of morphine equivalence/day) 4. Any methadone prescription to opioid naïve patient Any opioid prescription and … 5. smoking/COPD/emphysema/asthma or other respiratory illness 6. renal dysfunction, hepatic disease 7. known or suspected concurrent alcohol use 8. concurrent benzodiazepine prescription 9. concurrent SSRI or TCA anti-depressant prescription

Naloxone Prescribed When: 10. Prisoner released from custody 11. Release from opioid detoxification or mandatory abstinence program 12. Voluntary request from patient 13. Patients in methadone or buprenorphine detox/maintenance (for addiction or pain) 14. Patient may have difficulty accessing emergency medical services (distance, remoteness) 15. Other (specify): ____________________________________

Policy and Procedure Creation Intranasal Naloxone Policy Controlled Substances Policy Any patient with an opioid prescription can be ordered intranasal naloxone by either a nurse or pharmacist per protocol Any patient who has a known history of opioid misuse will be offered a prescription for intranasal naloxone after discussion with a prescribing practitioner

Patient Education Patients and family members or friends will watch the intranasal naloxone training video (produced by PPP) Staff will review the patient education checklist Patients will be given the opportunity to ask questions

Naloxone Dispensing at PHC After the patient has been educated, they will leave the clinic with naloxone in hand that has been dispensed from clinic stock The clinic stock will be replaced by placing an order with the clinic’s contract pharmacy The order will be adjudicated with the patient’s insurance, if applicable The replacement stock will be received at the clinic next day

Naloxone Dispensing at PHC

Challenges and Obstacles Mechanism for patient education that is sustainable Naloxone shortage EHR implementation Prescribers Raises uncomfortable issues for prescribers

Questions